21404_The Acute Coronary Syndrome Patient: Surveying the Landscape of Antiplatelet Therapy and Best

Gregg W. Stone, MD (Chair);Jeffrey S. Berger, MD, MS and Jessica L. Mega, MD, MPH lead discussions on Surveying the landscape of antiplatelet therapy and best practices in secondary prevention

Internists play a critical role in the longterm management of patients who have experienced an acute coronary syndrome (ACS). The landscape of antiplatelet therapy has changed with the addition of newer drugs; it is important for internists to be aware of similarities and differences between therapies and their use in post-ACS management. Optimal patient interactions after an ACS require a comprehensive knowledge of guideline-recommended lifestyle and pharmacologic therapies, as well as intensity, dosage, and duration of therapies. Patient adherence to a secondary prevention strategy, and effective internist-patient and internistcardiologist communication are important to reduce the risk of adverse cardiovascular events. This program will provide internists with a current overview of antiplatelet therapy for ACS patients, and state-of-the-art risk factor reduction strategies from recently released guidelines.

Login to your Account